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The function of the African swine fever virus (ASFV) bcl-2 homologue, gene A179L, in the regulation of apoptosis was
investigated using as a model system the human myeloid leukemia cell line K562 induced to die by apoptosis with inhibitors
of macromolecular synthesis, a process that is prevented by overexpression of human bcl-2. It is shown that transfection
of K562 cells with the ASFV A179L gene protects these cells from apoptotic cell death induced by a combination of
cycloheximide and actinomycin D or by treatment with cytosine arabinoside. To test the functional role of the highly
conserved BH1 domain present in the A179L protein, the Gly residue at position 85 was mutated to Ala, since it has been
shown that substitution of the corresponding Gly in human Bcl-2 abrogates its death-repressor activity. It was found that
the Gly-to-Ala mutation in the BH1 domain of the viral protein abolished its capacity to protect the K562 cells from apoptosis,
indicating that this Gly is essential for A179L action. This finding stresses the functional similarity of the BH1 domains of
the viral protein and cellular Bcl-2. q 1997 Academic Press
Apoptosis is an active cell death process that plays amounts of reactive radicals, which can trigger and/or
mediate the apoptotic process (10). In this connection, itimportant roles in development and homeostasis, as
well as in viral pathogenesis (reviewed in Ref. 1). It has is of interest to note that the virus contains, in addition
to the bcl-2 homologue, a second gene putatively in-been proposed that altruistic cell death might be used
as a defense mechanism during viral infections to pre- volved in the control of apoptosis, encoding a protein
similar to members of the IAP family of apoptosis inhibi-vent the death by infection of neighboring cells (2). To
tors (11).counteract this host defense mechanism, viruses have
The proteins encoded by the bcl-2 homologues of thebeen shown to contain genes involved in the regulation
virulent Malawi strain of ASFV (gene 5-HL) (5) and of theof apoptosis. Three viral genes encode proteins with
Vero cell-adapted strain BA71V (gene A179L) (6) shareamino acid sequence similarity to members of the Bcl-
96.6% identity and contain the two highly conserved do-2/Bax family of apoptosis regulators: the BHRF1 gene
mains, BH1 and BH2, characteristic of the family of Bcl-of Epstein – Barr virus, which protects human B cells
2-related proteins (12, 13). Mutations in these regions ofand the Chinese hamster ovary cell line from pro-
cellular Bcl-2 have been shown to abrogate its ability togrammed cell death (3, 4), the 5-HL and A179L genes
protect cells from apoptosis, apparently by disrupting itsof nonadapted and Vero-cell-adapted strains, respec-
heterodimerization with Bax, a Bcl-2 family member thattively, of African swine fever virus (ASFV) (5, 6), and
accelerates cell death (14).ORF 16 of herpesvirus saimiri (7).
The present study was undertaken to investigate theASFV, the causative agent of a severe disease of do-
functional properties of the A179L gene from ASFVmestic pigs, is a large DNA virus with an icosahedral
BA71V strain, by testing its effect on the apoptosis in-morphology that infects macrophages in its swine host,
duced by inhibitors of macromolecular synthesis in thealthough virus strains adapted to grow in established
human myeloid leukemia cell line K562, a process thatcell lines have been developed (reviewed in Ref. 8, 9).
can be prevented by overexpression of human bcl-2 (15).As has been discussed (6), inhibition of apoptosis could
We show that transfection of K562 cells with the ASFVbe particularly important for virus replication in its natural
A179L gene protects these cells from apoptotic cell deathtarget cell, since the macrophages can generate large
induced by macromolecular synthesis inhibitors, and that
a Gly-to-Ala substitution in the BH1 domain of the viral
gene abrogates its protective effect.1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 34-1-397 47 99. E-mail: mlsalas@mvax.cbm.uam.es. The A179L gene was PCR amplified using as primers
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oligonucleotides 5*-GCGGAATTCCACATGCTATATCAA-
ATTGCAG-3* (oligo 1) and 5*-GCGGAATTCTAGGGT-
GCCGCTATGGAGGGAG-3* (oligo 2), containing EcoRI
sites and GCG tails, and cloned into the EcoRI-digested
eukaryotic expression vector SFFV-Neo (16) under the
control of the long terminal repeat of the splenic focus-
forming virus (SFFV-A179L). Sequencing of the cloned
product was carried out to determine the orientation of
the A179L gene and to ensure that no mutations were
introduced during the PCR amplification. K562 cells, cul-
tured as described before (15), were transfected by elec-
troporation with the recombinant plasmid SFFV-A179L
or, as a control, with the empty SFFV-Neo vector. For
transfections, 10 mg of the plasmid was linearized with
SalI and resuspended in 10 mM Tris–HCl, pH 7.5; 1 mM
EDTA. Electroporation was carried out at 500 V, 750 mF,
and the cells were then selected for resistance to neomy-
cin by growth in the presence of 1 mg/ml G418 antibiotic.
K562 cells stably transfected with the human bcl-2 gene
cloned in the SFFV-Neo vector (15) were also used in
FIG. 1. Expression analysis of ASFV A179L and human bcl-2 in trans-these studies. Polyclonal populations of transfected cells
fected K562 cells. (A) Autoradiographs of Northern blots of RNA fromwere always used.
K562 cells transfected with SFFV-Neo (Neo), SFFV-A179L wild type (wt),The substitution of Gly 145 with Ala in the BH1 domain
or mutant Gly 85 to Ala (mt), and with SFFV-bcl-2 (bcl-2), hybridized
of human Bcl-2 has been shown to abrogate completely with 32P-labeled oligonucleotide probes specific for genes A179L (left)
its death-repressor activity. Accordingly, to test the func- or human bcl-2 (right). Hybridizations were carried out with 3 1 106
cpm/ml of the A179L probe (specific activity 1.6 1 105 cpm/ng) and 1.3tional role of the BH1 domain of the ASFV A179L protein,
1 106 cpm/ml of the bcl-2 probe (specific activity 6.0 1 104 cpm/ng).the equivalent Gly residue at position 85 of the viral pro-
The membranes were exposed with two intensifying screens for 4 hrtein was mutated to Ala. For this, site-specific mutagene-
after hybridization with the A179L probe, and for 19 hr after hybridization
sis was carried out by asymmetric PCR as described by with the bcl-2 probe. The sizes (in kilobases) of RNA molecular weight
Perrin and Gilliland (17). Briefly, a 281-nucleotide mega- markers are indicated on the left, and the size (in kilobases) of the
detected RNA bands is indicated on the right. (B) Western blot analysisprimer with the mutation incorporated was synthesized
of whole extracts from K562 cells transfected with SFFV-Neo (Neo),in a first PCR, using as primers the mutagenic oligonucle-
SFFV-A179L mutant (mt), or wild type (wt). The Western blot was carriedotide 5*-CAAATTCTCGCCCAGTTGATA-3* (the two nucle-
out as indicated, using the A179L-specific anti-peptide antiserum. The
otides changed are shown in boldface) and oligo 2, and sizes (in kDa) of protein markers are indicated on the left. The arrow
as template the SFFV-A179L plasmid linearized with SalI. indicates the A179L protein (pA179L).
In a second PCR, the megaprimer and oligo 1 were then
used as primers with the same plasmid template to am-
plify and introduce the mutation into the A179L gene. The plasmids SFFV-Neo, SFFV-A179L wild type, or SFFV-
A179L mutant were electrophoresed in SDS–polyacryl-mutated gene was cloned in vector SFFV-Neo, se-
quenced, and transfected into K562 cells as described amide gels and subsequently transferred to immobilon
membranes with a Mini Protean II apparatus (Bio-Rad),above.
The expression of wild-type or mutant A179L gene in according to the manufacturer’s instructions. A 16-amino-
acid peptide, corresponding to positions 26 to 41 of thetransfected cells was determined by RNA hybridization
and Western blot analyses. The RNA samples were ob- ASFV A179L protein (NH2-DISEHELSPYQQQIKK-COOH),
a region not conserved in cellular Bcl-2, was conjugatedtained from cultures of transfected cells by the method
of Chomczynski and Sacchi (18). For Northern blot, 15 mg to keyhole limpet hemocyanin (KLH) and used to immu-
nize rabbits. The immune serum obtained recognized inof total RNA was fractionated on formaldehyde–agarose
oligonucleotides 5*-GCTCATGCTCTGAAATATCATTAA- Western blots a recombinant A179L protein cloned in
pGEX vector (AMRAD Corp. Limited) and expressed inTGTAATA-3* or 5*-CTCTGCGACAGCTTATAATG-3*, spe-
cific for genes A179L and human bcl-2, respectively, as Escherichia coli (not shown). The immobilon membranes
were blocked in TBS (20 mM Tris–HCl, pH 7.5; 500 mMpreviously described (19). As shown in Fig. 1A, an RNA
band of 2 kb was detected in cells transfected with the NaCl) with 3% dry milk powder for 30 min and then incu-
bated overnight at 47 with the A179L-specific anti-peptidewild-type or mutant A179L gene, or with the human bcl-
2 gene, but not in the control cells transfected with the antiserum diluted 1/500 in TBS with 5% dry milk powder.
After washing with TBS–0.05% Tween, the membranesSFFV-Neo vector.
For Western blot, equivalent amounts (350,000 cells) were incubated with goat anti-rabbit peroxidase diluted
1/5000 in TBS with 5% dry milk powder and 0.05% Tween.of whole cell extracts from K562 cells transfected with
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FIG. 2. Flow cytometry of the DNA content of transfected K562 cells. K562 cells transfected with SFFV-Neo (Neo), SFFV-bcl-2 (Bcl-2), and SFFV-
A179L wild type (A179L wt) or mutant Gly 85 to Ala (A179L mt) were incubated for 48 hr in the absence of inhibitors (untreated) or in the presence
of 25 mg/ml of CHM and 0.1 mg/ml of Act D (treated). The DNA content of the cells was determined by flow cytometry after propidium iodide (PI)
staining (20).
Protein detection was carried out with an electrochemo- cells with a combination of protein and RNA synthesis
inhibitors induces apoptotic cell death in these cells (15).luminescence system (ECL system, Amersham) ac-
cording to the manufacturer’s recommendations. As To test the effect of ASFV A179L gene in this system,
transfected K562 cells were cultured as described (15)shown in Fig. 1B, the K562 cells transfected with plas-
mids carrying wild-type or mutant A179L gene expressed in the presence of 25 mg/ml of cycloheximide (CHM) and
0.1 mg/ml of actinomycin D (Act D), and the distributionsimilar amounts of wild-type or mutant A179L protein,
while in the cells transfected with the SFFV-Neo plasmid of cellular DNA content was determined by flow cytome-
try after propidium iodide staining, as described (20) (Fig.this protein was not detected.
It has been previously shown that incubation of K562 2). After 48 hr of incubation of the cells in the absence
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The DNA synthesis inhibitor cytosine arabinoside (Ara
C) has also been found to induce apoptosis in the my-
eloid cell line K562 (15). Figure 4 shows that only 20% of
the K562-Neo cells survived after 168 hr of treatment with
10 mM Ara C. The percentage of surviving cells increased
to 48% in the case of cells expressing the human bcl-2
and to 35% in the K562 cells transfected with the wild-
type A179L gene. In contrast, and in keeping with the
results obtained with the protein and RNA synthesis in-
hibitors, the mutant viral gene did not confer protection
from Ara C-induced apoptosis.
Different members of the Bcl-2/Bax family of proteins
can have opposing effects on apoptosis. Thus, while Bcl-
2 and Bcl-xL are suppressors of apoptosis (12, 21, 22),
other proteins of this family, such as Bax, Bak, and Bcl-
xS , have been shown to accelerate cell death (23–27).
The results presented here indicate that ASFV A179L andFIG. 3. Protection by A179L and Bcl-2 from apoptosis induced in
human Bcl-2 are functionally homologous in their effectsK562 cells by CHM and Act D. K562 cells transfected with SFFV-Neo
(Neo), SFFV-bcl-2 (Bcl-2), and SFFV-A179L wild type (A179L wt) or mu- upon cell survival, both proteins affording significant pro-
tant Gly 85 to Ala (A179L mt) were incubated with 25 mg/ml of CHM tection against the cell death induced by macromolecular
and 0.1 mg/ml of Act D and, at the indicated time points, cell death synthesis inhibitors in human myeloid cells. The viral
was determined by analyzing the DNA content of the cells by flow
gene could, therefore, play a similar protective role dur-cytometry after propidium iodide staining. The results are represented
ing infection, prolonging the lifetime of infected cells andas the percentage of surviving cells. The data represent the mean of
two experiments. The percentage of cells surviving after incubation in thus maximizing the production of progeny virus. The
medium without the inhibitors at the different time points was 90% finding that, during the infection, expression of the gene
for the K562 cells transfected with the different plasmids. is induced at early times supports this possibility (5).
We have also observed that when Gly 85 in BH1 do-
of inhibitors, expression of human bcl-2 or of the ASFV main was mutated to Ala, the protective effect of the
A179L gene, wild-type or mutated, did not significantly
affect the cell cycle distribution observed in K562 cells
transfected with the SFFV-Neo vector. Addition of inhibi-
tors greatly increased the proportion of the cells with a
DNA content 2n in cells transfected with the control
vector, while in cells expressing the human bcl-2 the cell
cycle profile was essentially identical to that obtained in
the absence of inhibitors. On the other hand, in cells
expressing the wild-type A179L gene, the percentage of
the population with a DNA content 2n was consider-
ably smaller than that observed in cells transfected with
the control vector. In contrast, mutation of the virus gene
induced a considerable increase in the number of cells
with a lower DNA content, the cell cycle profile being
very similar to that found in the control cells.
Figure 3 presents a time course of the apoptosis in-
duced by CHM and Act D in transfected K562 cells. The
data shown represent the average of two independent
experiments. It can be seen that treatment of K562-Neo
cells with the drugs induced a time-dependent cell death,
assayed by flow cytometry as described above. The ef-
FIG. 4. Protection by A179L and Bcl-2 from apoptosis induced in
fect of the drugs was counteracted by overexpression K562 cells by Ara C. K562 cells transfected with SFFV-Neo (Neo), SFFV-
of human bcl-2 in the K562-Bcl-2-cells. Protection from bcl-2 (Bcl-2), and SFFV-A179L wild type (A179L wt) or mutant Gly 85
to Ala (A179L mt) were incubated with 10 mM Ara C for 168 hr, andapoptosis was also observed by overexpression of the
cell death was determined as described in the legend to Fig. 3. Theviral A179L gene, although to a somewhat lesser extent.
results are represented as the percentage of surviving cells. The dataOn the other hand, the substitution of Gly 85 with Ala in
represent the mean of three experiments { standard deviation. The
the BH1 domain of the A179L protein abolished almost percentage of cells surviving after incubation for 168 hr in medium
completely its capacity to protect the K562 cells from the without the inhibitors was 90% for the K562 cells transfected with
the different plasmids.apoptosis triggered by the addition of CHM plus Act D.
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